Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program
04 Dezembro 2023 - 10:00AM
AllPennyStocks.com
Obesity and diabetes have become a problem for developed world
countries. To address the global rise of these issues, this company
is pursuing a dual-gene therapy strategy using
proprietary...
To read the full story on AllPennyStocks.com, click
here.
PreveCeutical Medical (QB) (USOTC:PRVCF)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
PreveCeutical Medical (QB) (USOTC:PRVCF)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre PreveCeutical Medical Inc (QB) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de PreveCeutical Medical Inc (QB)